GlassScriptPhysician profile
Trent B Giles
NPI 1457738841
$7,885.65
in general payments reported to CMS, 2019-2025
45 companies · $2,211 in 2025
The $2,211 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $609 · 2020: $259 · 2021: $16.10 · 2022: $725 · 2023: $1,986 · 2024: $2,080 · 2025: $2,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,277.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,007.24 | 2019-2025 | |
| Abbvie INC. | $944.78 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $892.99 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $776.23 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $655.88 | 2019-2025 | Repatha, Evenity, Repatha |
| Corcept Therapeutics | $502.23 | 2022-2025 | Korlym |
| Lilly USA, LLC | $351.46 | 2019-2025 | Zepbound, Mounjaro, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $284.49 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $240.79 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $227.68 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $199.57 | 2019-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $178.93 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $148.95 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $146.03 | 2019-2025 | |
| Dexcom, INC. | $134.79 | 2023-2025 | Dexcom G6 Transmitter |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trent Giles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.